Halbert Hargrove Global Advisors, LLC Moderna, Inc. Transaction History

Halbert Hargrove Global Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $107,870 - $200,497	-853 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $2,258 - $3,685	-10 Reduced 1.16%	853 $217,000
Q3 2021 Oct 29, 2021	BUY	$221.9 - $484.47 $191,499 - $418,097	863 New	863 $332,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Halbert Hargrove Global Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Halbert Hargrove Global Advisors, LLC with notifications on news.